PB1966: THE EFFECT OF BODY MASS INDEX ON THE SAFETY OF BOSUTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A POST HOC POOLED DATA ANALYSIS

• Susanne Isfort,
• Carlo Gambacorti-Passerini,
• Tim H Brümmendorf,
• B. Douglas Smith,
• Simon Purcell,
• Huadong Zhao,
• Luke Kuttschreuter,
• Jane Apperley

Affiliations

Susanne Isfort

1 Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany

Carlo Gambacorti-Passerini

3 University of Milano Bicocca, Monza, Italy

Tim H Brümmendorf

1 Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany

B. Douglas Smith

4 John Hopkins University School of Medicine, Baltimore, United States

Simon Purcell

5 Pfizer Ltd, London, United Kingdom

Huadong Zhao

6 Pfizer (China) R&D Co., Ltd, Shanghai, China

Luke Kuttschreuter

7 Pfizer Ltd, Oxford, United Kingdom

Jane Apperley

8 Imperial College London, London, United Kingdom